Neurodegenerative disease profoundly affects structures and pathways responsible for memory, cognition, and higher-order ...
Alzheimer disease (AD) is the most common cause of dementia and one of the leading causes of death in adults age 65 y or ...
Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...
The approval of disease-modifying antiamyloid therapies has expanded the clinical role of amyloid PET beyond diagnostic confirmation to include baseline characterization and longitudinal monitoring of ...
The growing demand for amyloid and tau PET imaging, driven by new dementia therapies and biomarker-based diagnosis, has increased the need for accessible PET brain imaging in outpatient neurology ...
Journal of Nuclear Medicine Technology February 2026, jnmt.125.271265; DOI: https://doi.org/10.2967/jnmt.125.271265 ...
Journal of Nuclear Medicine Technology February 2026, jnmt.125.271835; DOI: https://doi.org/10.2967/jnmt.125.271835 ...
Neurodegenerative diseases are characterized by progressive neuronal dysfunction, synaptic loss, and decline in cognitive, behavioral, or motor function. Understanding these disorders requires a ...
Journal of Nuclear Medicine Technology February 2026, jnmt.125.271428; DOI: https://doi.org/10.2967/jnmt.125.271428 ...
Journal of Nuclear Medicine Technology February 2026, jnmt.125.271678; DOI: https://doi.org/10.2967/jnmt.125.271678 Alzheimer disease (AD) is the most common cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results